First Page | Document Content | |
---|---|---|
![]() Date: 2007-11-07 12:45:18Pharmaceuticals policy Food and Drug Administration Pharmaceutical industry Piperazines Norfloxacin New Drug Application Levothyroxine Generally recognized as safe and effective Federal Food Drug and Cosmetic Act Pharmaceutical sciences Medicine Pharmacology | Source URL: www.fda.govDownload Document from Source WebsiteFile Size: 887,39 KBShare Document on Facebook |
![]() | Federal Register / Vol. 72, No[removed]Tuesday, May 29, [removed]Notices Dated: May 22, 2007. Jeffrey Shuren, Assistant Commissioner for Policy. [FR Doc. E7–10271 Filed 5–25–07; 8:45 am] BILLING CODE 4160–01–SDocID: ZGX8 - View Document |
![]() | +(,121/,1( Citation: 52 Fed. Reg[removed]Content downloaded/printed from HeinOnline (http://heinonline.org) Wed Oct 29 14:50:[removed]DocID: M6XG - View Document |
![]() | [removed]Proposed Rules Federal Register Vol. 73, No. 119DocID: J5ch - View Document |
![]() | Microsoft Word - S[removed]Sunscreen Innovation ActDocID: HHm5 - View Document |
![]() | Microsoft Word - S[removed]Sunscreen Innovation ActDocID: HoBD - View Document |